Jennifer Lyn Herron

Insider Reports History

Entity
Individual
Location
C/O Genocea Biosciences, Inc., 100 Acorn Park Drive 5 Th Floor, Cambridge, MA
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Lyn Herron:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GENOCEA BIOSCIENCES, INC. Director Stock Option (Right to Buy) 30K Sep 9, 2021 Direct
ChemoCentryx, Inc. Director Common Stock 0 $50.95 Oct 20, 2022 Direct

Insider Reports Filed by Jennifer Lyn Herron

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCXI ChemoCentryx, Inc. Oct 20, 2022 1 $0 4 Oct 24, 2022 Director
CCXI ChemoCentryx, Inc. Jun 28, 2022 1 $0 4 Jun 30, 2022 Director
CCXI ChemoCentryx, Inc. Jun 28, 2022 0 $0 3 Jun 30, 2022 Director
GNCA GENOCEA BIOSCIENCES, INC. Sep 9, 2021 1 $0 4 Sep 28, 2021 Director
GNCA GENOCEA BIOSCIENCES, INC. Sep 8, 2021 0 $0 3 Sep 28, 2021 Director